Hearing disorders can be treated with multifunctional nanoliposome therapy

Nov 20, 2012
Hearing disorders can be treated with multifunctional nanoliposome therapy

Liposomes are used in contemporary medicine to carry and apply drugs and genes into different tissue areas of the body. They are small bubble-shaped lipid molecules, and an attractive candidate for delivery because they are composed of the same material as cell membranes. Several types of cancer, for instance, are treated with liposome therapy.

Nano-sized liposomes would remarkably improve the precision and effectiveness of drug and gene delivery. A few such technologies already exist in the market and in clinical use, but cell-specific delivery is still a property to be explored in nanomedicine.

Sanjeev Ranjan has studied the use of liposome in the treatment of inner ear disorders. His doctoral dissertation for the Aalto University Department of Biomedical Engineering and looks into the manufacturing of nanoliposomes, their use in drug and gene delivery, and also into imaging techniques. With further research Ranjan expects all these properties to be combined into a single multifunctional nanoparticle.

"Liposomes are currently the most advanced nanoparticles for delivering drugs and genes in vivo. Their main problem is that they cannot be exactly targeted to desired cells with ," Ranjan points out.

Ranjan's research has been a part of the EU-funded project NanoEar spanning 24 universities. WHO estimated in 2004 that at least 275 million people suffer from hear loss or around the world. NanoEar aims to provide multifunctional nanoparticles for clinical therapy.

Drugs and genes applied with cell-to-cell precision by nanoliposomes

With nanotechnology very precise targeting of liposome therapy becomes possible. Ranjan and his colleagues have come up with a new for manufacturing liposome nanoparticles, which can be delivered into the inner ear and inside the cochlea.

"The technique is very fast, non-invasive, there is no loss of materials, and it can be used in large scale – these are all benefits in comparison to nanoliposomes prepared with other currently available ultrasound methods," Ranjan explains.

In gene therapy, foreign genes are introduced to the body to fix impairments. In the inner ear, inside the cochlea, there are neurons called hair cells, damages to which result in hearing loss.

A schematic illustration of an ideal multifunctional liposome with encapsulated drugs and genes, imaging agent, cell-penetrating agent and specific targeting moiety.

Ranjan and his colleagues have studied the targeted delivery of liposomes encapsulated with Math1-, which aid hair cells to survive. They have designed peptides with computer modelling and phage display and conjugated them to the liposome nanoparticles to be delivered into the cochlea.

"The nanoparticles are introduced to specific receptors in specific cells, and the encapsulated new gene will begin to express in the cells.

"The current clinical supplement for this kind of treatment is a highly expensive cochlear implant. Our research could make the treatment of cochlea damages much more affordable and accessible."

In order to effectively control the functioning of the particles, visualising techniques are needed. Ranjan has studied the applicability of magnetic resonance imaging (MRI) to nanoliposomes. The particles can be tracked with MRI by tagging them with visualising substances.

"It is crucial for doctors to be able to visualise the inner ear. There is no way to directly image the inside of the cochlea, which is inside bone structures in the skull. We developed nanoparticles that can be imaged with MRI in the ."

Multifunctional nanoparticles to make a break in nanomedicine?

All the properties Ranjan has studied in the nanoliposomes – targeted drug and and traceability with MRI – could be combined in one multifunctional nanoparticle.

"They are in high demand in nanomedicine. The particles containing MRI contrast agents that we have designed are a step towards realising multifunctionality."

The research on manufacturing multifunctional nanoparticles is well under way in Ranjan's research group. Ranjan and his supervisor Professor Paavo Kinnunen are planning a start-up business to commercialise their research into a product for clinical use.

"We are already very advanced in the technology and with our prototype of the product," confirms Professor Kinnunen.

Explore further: Gold nanoparticles help target, quantify breast cancer gene segments in a living cell

More information: lib.tkk.fi/Diss/2012/isbn9789526048383/isbn9789526048383.pdf

add to favorites email to friend print save as pdf

Related Stories

DNA nanoparticles to carry drugs and gene therapy

Apr 22, 2011

(PhysOrg.com) -- DNA isn't just for genetics anymore. Cornell researchers are using synthetic DNA to make nanoparticles, dubbed DNAsomes, that can deliver drugs and genetic therapy to the insides of cells.

Self-Assembling Nanoparticles Image Tumor Cells

Jul 23, 2007

By taking advantage of the full range of ways in which molecules can interact with and bind to one another, a team of investigators at the Carolina Center of Cancer Nanotechnology Excellence has created nanoparticles that ...

Recommended for you

Cloaked DNA nanodevices survive pilot mission

Apr 22, 2014

It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system. Now scientists at ...

Innovative strategy to facilitate organ repair

Apr 18, 2014

A significant breakthrough could revolutionize surgical practice and regenerative medicine. A team led by Ludwik Leibler from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur ...

User comments : 0

More news stories

Research proves nanobubbles are superstable

The intense research interest in surface nanobubbles arises from their potential applications in microfluidics and the scientific challenge for controlling their fundamental physical properties. One of the ...

One in 13 US schoolkids takes psych meds

(HealthDay)—More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.

FDA reconsiders behavior-modifying 'shock devices'

(HealthDay)—They're likened to a dog's "shock collar" by some and called a "life-saving treatment" by others. But the days of electro-shock devices as a tool for managing hard-to-control behavior in people ...

Computer program could help solve arson cases

Sifting through the chemical clues left behind by arson is delicate, time-consuming work, but University of Alberta researchers teaming with RCMP scientists in Canada, have found a way to speed the process.